PDF herunterladen
Z Gastroenterol 2022; 60(06): 288-391
DOI: 10.1055/a-1771-6893
Leitlinienreport

Leitlinienreport der S3-Leitlinie zum exokrinen Pankreaskarzinom

Version 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL
Thomas Seufferlein
1   Klinik für Innere Medizin I, Universitätsklinikum Ulm, Germany
,
Julia Mayerle
2   Klinik für Innere Medizin II, LMU München, Germany
,
Susanne Blödt
3   AWMF-Institut für Medizinisches Wissensmanagement, Berlin, Germany
,
Steffi Derenz
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Markus Follmann
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Angelika Kestler 
1   Klinik für Innere Medizin I, Universitätsklinikum Ulm, Germany
,
Marie-Jolin Köster
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Thomas Langer
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Dana Rütters
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Simone Wesselmann
4   Deutsche Krebsgesellschaft (DKG), Berlin, Germany
,
Pia Lorenz
5   Deutsche Gesellschaft für Gastroneterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS), Berlin, Germany
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  Lizenzen und Reprints

Schlüsselwörter

Pankreaskarzinom - S3 Leitlinie - duktales Adenokarzinom des Pankreas - evidenzbasierte Medizin

Key words

pancreatic cancer - S3 guideline - ductal adenocarcinoma of the pancreas - evidence based medicine

Supporting information



Publikationsverlauf

Eingereicht: 24. Januar 2022

Angenommen: 14. Februar 2022

Artikel online veröffentlicht:
14. Juni 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 European Study Group on Cystic Tumours of the P. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67: 789-804
    Suche in Google Scholar
  • 2 Tanaka M. et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17 (05) 738-753
    Suche in Google Scholar
  • 3 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., AWMF). Entwicklung von leitlinienbasierten Qualitätsindikatoren. Methodenpapier für das Leitlinienprogramm Onkologie, Version 2.1. 2017. Available from: http://www.leitlinienprogramm-onkologie.de/methodik/informationen-zur-methodik/
    PubMed
  • 4 Stoffel EM. et al. Evaluating susceptibility to pancreatic cancer: ASCO provisional clinical opinion. Journal of Clinical Oncology 2019; 37 (02) 153-164
    Suche in Google Scholar
  • 5 Goggins M. et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut 2019; 69 (01) 7-17
    CrossrefPubMedSuche in Google Scholar
  • 6 Khorana AA. et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016; 34 (21) 2541-2556
    Suche in Google Scholar
  • 7 Sohal DPS. et al. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 2016; 34 (23) 2784-2796
    Suche in Google Scholar
  • 8 National Institute for, H. and E. Care, Pancreatic cancer in adults: diagnosis and management. NICE Guideline NG85. London: NICE; 2018
    Suche in Google Scholar
  • 9 Sohal DPS. et al. Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology 2018; 36 (24) 2545-2556
    Suche in Google Scholar
  • 10 Lachter J. et al. Establishing a quality indicator format for endoscopic ultrasound. World J Gastrointest Endosc 2013; 5 (11) 574-580
    CrossrefPubMedSuche in Google Scholar
  • 11 Mackay TM. et al. Nationwide compliance with a multidisciplinary guideline on pancreatic cancer during 6-year follow-up. Pancreatology 2020; 20 (08) 1723-1731
    CrossrefPubMedSuche in Google Scholar
  • 12 Maharaj AD. et al. Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. HPB (Oxford) 2018; 21 (04) 444-455
    CrossrefPubMedSuche in Google Scholar
  • 13 Maharaj AD. et al. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers. BMJ Open 2019; 9 (09) e031434
    CrossrefPubMedSuche in Google Scholar
  • 14 Mizuma M. et al. Impact of a board certification system and implementation of clinical practice guidelines for pancreatic cancer on mortality of pancreaticoduodenectomy. Surg Today 2020; 50 (10) 1297-1307
    CrossrefPubMedSuche in Google Scholar
  • 15 Sabater L. et al. Outcome quality standards in pancreatic oncologic surgery. Ann Surg Oncol 2014; 21 (04) 1138-1146
    CrossrefPubMedSuche in Google Scholar
  • 16 Sabater L. et al. Outcome Quality Standards in Pancreatic Oncologic Surgery in Spain. Cirugía Española (English Edition) 2018; 96 (06) 342-351
    CrossrefPubMedSuche in Google Scholar
  • 17 Solomon D. et al. Assessing the Implementation of American College of Surgeons Quality Indicators for Pancreatic Cancer Across an Integrated Health System. J Oncol Pract 2019; 15 (08) e739-e745
    CrossrefPubMedSuche in Google Scholar
  • 18 van Rijssen LB. et al. National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma. Pancreatology 2016; 16 (01) 133-137
    CrossrefPubMedSuche in Google Scholar
  • 19 van Rijssen LB. et al. Nationwide prospective audit of pancreatic surgery: design, accuracy, and outcomes of the Dutch Pancreatic Cancer Audit. HPB (Oxford) 2017; 19 (10) 919-926
    CrossrefPubMedSuche in Google Scholar
  • 20 Wani S. et al. Quality indicators for EUS. Gastrointest Endosc 2015; 81 (01) 67-80
    CrossrefPubMedSuche in Google Scholar
  • 21 Wellner UF. et al. Qualitatsindikatoren fur die Pankreaschirurgie: Wissenschaftliche Herleitung und klinische Relevanz. Chirurg 2018; 89 (01) 32-39
    CrossrefPubMedSuche in Google Scholar
  • 22 Wellner UF, Keck T. Quality Indicators in Pancreatic Surgery: Lessons Learned from the German DGAV StuDoQ|Pancreas Registry. Visc Med 2017; 33 (02) 126-130
    CrossrefPubMedSuche in Google Scholar
  • 23 Agency for Healthcare Research and Quality (AHRQ). Inpatient Quality Indicator 09 (IQI 09) Pancreatic Resection Mortality Rate. Rockville: AHRQ; 2020
    Suche in Google Scholar
  • 24 National Quality Forum (NQF). Quality Positioning System (QPS). Measure Description Display Information. 2020 18.12.2020. Available from: http://www.qualityforum.org/QPS/QPSTool.aspx
    PubMed
  • 25 Scottish Cancer Taskforce National Cancer Quality Steering Group. HepatoPancreatoBiliary Cancer. Clinical Quality Performance Indicators. 2020 12.10.2020; Available from: http://www.healthcareimprovementscotland.org/our_work/cancer_care_improvement/cancer_qpis/quality_performance_indicators.aspx
    PubMedSuche in Google Scholar